Literature DB >> 24152963

Protective effects of a dietary carotenoid, astaxanthin, against light-induced retinal damage.

Tomohiro Otsuka1, Masamitsu Shimazawa, Tomohiro Nakanishi, Yuta Ohno, Yuki Inoue, Kazuhiro Tsuruma, Takashi Ishibashi, Hideaki Hara.   

Abstract

Dietary carotenoids exhibit various biological activities, including antioxidative activity. In particular, astaxanthin, a type of carotenoid, is well known as a powerful antioxidant. We investigated whether astaxanthin would protect against light-induced retinal damage. In an in vivo study, ddY male mice were exposed to white light at 8,000 lux for 3 h to induce retinal damage. Five days after light exposure, retinal damage was evaluated by measuring electroretinogram (ERG) amplitude and outer nuclear layer (ONL) thickness. Furthermore, expression of apoptotic cells, 8-hydroxy-deoxyguanosine (8-OHdG), was measured. In an in vitro study, retinal damage was induced by white light exposure at 2,500 lux for 24 h, and propidium iodide (PI)-positive cells was measured and intracellular reactive oxygen species (ROS) activity was examined. Astaxanthin at 100 mg/kg inhibited the retinal dysfunction in terms of ERG and ONL loss and reduced the expression of apoptotic and 8-OHdG-positive cells induced by light exposure. Furthermore, astaxanthin protected against increases of PI-positive cells and intracellular reactive oxygen species (ROS) activity in 661W cells. These findings suggest that astaxanthin has protective effects against light-induced retinal damage via the mechanism of its antioxidative effect.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24152963     DOI: 10.1254/jphs.13066fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  10 in total

1.  Placoid choroidopathy after bilateral uncomplicated descemet's membrane endothelial keratoplasty.

Authors:  Thomas H Dohlman; Neepa Shah; Colin Prensky; Mrinali P Gupta; Donald J D'Amico; Szilard Kiss; Christopher S Sales
Journal:  Am J Ophthalmol Case Rep       Date:  2020-02-01

Review 2.  Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases.

Authors:  Ming Yang; Yanling Wang
Journal:  J Ophthalmol       Date:  2022-05-20       Impact factor: 1.974

3.  Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt's Disease.

Authors:  Maxime Vincent; Laurianne Simon; Philippe Brabet; Philippe Legrand; Christophe Dorandeu; Josephine Lai Kee Him; Thierry Durand; Céline Crauste; Sylvie Begu
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

4.  Combined effect of astaxanthin and squalene on oxidative stress in vivo.

Authors:  Sangeetha Ravi Kumar; Bhaskar Narayan; Yuki Sawada; Masashi Hosokawa; Kazuo Miyashita
Journal:  Mol Cell Biochem       Date:  2016-05-17       Impact factor: 3.396

Review 5.  A role of Heat Shock Protein 70 in Photoreceptor Cell Death: Potential as a Novel Therapeutic Target in Retinal Degeneration.

Authors:  Ayako Furukawa; Yoshiki Koriyama
Journal:  CNS Neurosci Ther       Date:  2015-10-28       Impact factor: 5.243

6.  Oxidative Stress Regulation on Endothelial Cells by Hydrophilic Astaxanthin Complex: Chemical, Biological, and Molecular Antioxidant Activity Evaluation.

Authors:  M Zuluaga; A Barzegari; D Letourneur; V Gueguen; G Pavon-Djavid
Journal:  Oxid Med Cell Longev       Date:  2017-09-27       Impact factor: 6.543

7.  Haematococcus pluvialis-Derived Astaxanthin Is a Potential Neuroprotective Agent against Optic Nerve Ischemia.

Authors:  Wei-Ning Lin; Kishan Kapupara; Yao-Tseng Wen; Yi-Hsun Chen; I-Hong Pan; Rong-Kung Tsai
Journal:  Mar Drugs       Date:  2020-01-28       Impact factor: 5.118

Review 8.  Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights.

Authors:  Giuseppe Giannaccare; Marco Pellegrini; Carlotta Senni; Federico Bernabei; Vincenzo Scorcia; Arrigo Francesco Giuseppe Cicero
Journal:  Mar Drugs       Date:  2020-05-01       Impact factor: 5.118

9.  Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma.

Authors:  Shohei Tsuji; Shinsuke Nakamura; Takashi Maoka; Tetsuya Yamada; Takahiko Imai; Takuya Ohba; Tomohiro Yako; Masahiro Hayashi; Ken Endo; Masanao Saio; Hideaki Hara; Masamitsu Shimazawa
Journal:  Mar Drugs       Date:  2020-09-18       Impact factor: 5.118

10.  Protective Effects of Oral Astaxanthin Nanopowder against Ultraviolet-Induced Photokeratitis in Mice.

Authors:  Fumiya Harada; Tetsuro Morikawa; Anton Lennikov; Anthony Mukwaya; Mira Schaupper; Osamu Uehara; Rie Takai; Koki Yoshida; Jun Sato; Yukihiro Horie; Hiroyuki Sakaguchi; Ching-Zong Wu; Yoshihiro Abiko; Neil Lagali; Nobuyoshi Kitaichi
Journal:  Oxid Med Cell Longev       Date:  2017-09-28       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.